丁丙诺啡临床应用的实际考量
Practical considerations for the clinical use of buprenorphine.
作者信息
Jones Hendree E
机构信息
Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA.
出版信息
Sci Pract Perspect. 2004 Aug;2(2):4-20. doi: 10.1151/spp04224.
Abstract
Buprenorphine is a new and attractive medication option for many opioid-addicted adults and their physicians. Before initiating buprenorphine treatment, providers must be aware of such critical factors as how the medication works, its efficacy and safety profile, how it is used in opioid withdrawal as well as maintenance treatment, and how patients can best be selected, educated about buprenorphine, and monitored throughout treatment. This article reviews these important issues as well as requirements for physician and staff training and needs for additional research on this unique medication.
摘要
丁丙诺啡对于许多阿片类药物成瘾的成年人及其医生来说是一种新型且有吸引力的药物选择。在开始丁丙诺啡治疗之前，医疗服务提供者必须了解一些关键因素，比如该药物的作用机制、疗效和安全性概况、在阿片类药物戒断以及维持治疗中的使用方法，以及如何最好地选择患者、对其进行丁丙诺啡相关教育并在整个治疗过程中进行监测。本文回顾了这些重要问题以及医生和工作人员培训的要求，还有对这种独特药物进行更多研究的需求。
相似文献
1
Practical considerations for the clinical use of buprenorphine.
Sci Pract Perspect. 2004 Aug;2(2):4-20. doi: 10.1151/spp04224.
2
Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.
Am J Addict. 2004;13 Suppl 1(Suppl 1):S42-66. doi: 10.1080/10550490490440807.
3
Expanded table: Some drugs for management of opioid withdrawal symptoms.
Med Lett Drugs Ther. 2018 Aug 27;60(1554):e144-e146.
4
Buprenorphine in the treatment of opiate dependence.
J Psychoactive Drugs. 2010 Jun;42(2):161-75. doi: 10.1080/02791072.2010.10400689.
5
Management of opioid withdrawal symptoms.
Med Lett Drugs Ther. 2018 Aug 27;60(1554):137-141.
6
Managing opioid dependence. Comparing buprenorphine with methadone.
Can Fam Physician. 2003 Jul;49:876-7.
7
Narrative review: buprenorphine for opioid-dependent patients in office practice.
Ann Intern Med. 2008 May 6;148(9):662-70. doi: 10.7326/0003-4819-148-9-200805060-00006.
8
The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence.
Expert Opin Pharmacother. 2009 Oct;10(15):2537-44. doi: 10.1517/14656560903213405.
9
Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study.
Drug Alcohol Depend. 2010 Mar 1;107(2-3):253-6. doi: 10.1016/j.drugalcdep.2009.10.014. Epub 2009 Nov 30.
10
Buprenorphine and naloxone interactions in methadone maintenance patients.
Biol Psychiatry. 1997 Jun 1;41(11):1095-101. doi: 10.1016/S0006-3223(96)00266-1.
引用本文的文献
1
[Challenges in the treatment of opioid dependence].
Nervenarzt. 2024 Sep;95(9):811-817. doi: 10.1007/s00115-024-01691-9. Epub 2024 Jul 15.
2
Intraperitoneal injection of buprenorphine on anxiety-like behavior and alteration in expression of and in methamphetamine treated rats.
Vet Res Forum. 2022 Sep;13(3):417-422. doi: 10.30466/vrf.2021.140211.3111. Epub 2022 Sep 15.
3
Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial.
Addict Sci Clin Pract. 2022 Sep 4;17(1):47. doi: 10.1186/s13722-022-00326-1.
4
Outpatient Microdose Induction with Transdermal Buprenorphine: A Case Series.
Healthcare (Basel). 2022 Jul 14;10(7):1307. doi: 10.3390/healthcare10071307.
5
"You're Not Supposed to be on it Forever": Medications to Treat Opioid Use Disorder (MOUD) Related Stigma Among Drug Treatment Providers and People who Use Opioids.
Subst Abuse. 2022 Jun 27;16:11782218221103859. doi: 10.1177/11782218221103859. eCollection 2022.
6
Sex specific effects of buprenorphine on behavior, astrocytic opioid receptor expression and neuroinflammation after pediatric traumatic brain injury in mice.
Brain Behav Immun Health. 2022 May 13;22:100469. doi: 10.1016/j.bbih.2022.100469. eCollection 2022 Jul.
7
Management of Psychiatric Disorders in Patients with Cardiovascular Diseases.
Indian J Psychiatry. 2022 Mar;64(Suppl 2):S355-S365. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_42_22. Epub 2022 Mar 23.
8
Microdose induction of buprenorphine-naloxone in a patient using high dose methadone: A case report.
Ment Health Clin. 2021 Nov 8;11(6):369-372. doi: 10.9740/mhc.2021.11.369. eCollection 2021 Nov.
9
New Approaches in Drug Dependence: Opioids.
Curr Addict Rep. 2021;8(2):298-305. doi: 10.1007/s40429-021-00373-9. Epub 2021 May 26.
10
Successful Transition from High-Dose Methadone to Buprenorphine via Microdosing in the Outpatient Setting: A Case Report.
Can J Hosp Pharm. 2021 Winter;74(1):83-85. Epub 2021 Jan 1.
本文引用的文献
1
The feasibility of abrupt methadone-buprenorphine transfer in British opiate addicts in an outpatient setting.
Addict Biol. 1997 Apr;2(2):191-200. doi: 10.1080/13556219772732.
2
Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.
N Engl J Med. 2003 Sep 4;349(10):949-58. doi: 10.1056/NEJMoa022164.
3
In-office opiate treatment "not a panacea": physicians slow to embrace therapeutic option.
JAMA. 2003 Aug 13;290(6):731-5. doi: 10.1001/jama.290.6.731.
4
The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients.
Clin Infect Dis. 2003 Aug 15;37(4):476-82. doi: 10.1086/376907. Epub 2003 Aug 1.
5
Lack of methadone dose alterations or withdrawal symptoms during therapy with lopinavir/ritonavir.
J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):650-1. doi: 10.1097/00126334-200308150-00016.
6
[Opiates withdrawal syndrome after treatment with zidovudine + lamivudine + abcavir in patients with positivity for HIV and treated with methadone].
Rev Clin Esp. 2003 Aug;203(8):407-8. doi: 10.1157/13049447.
7
Buprenorphine dosing regime for inpatient heroin withdrawal: a symptom-triggered dose titration study.
Drug Alcohol Depend. 2003 Jun 5;70(3):287-94. doi: 10.1016/s0376-8716(03)00015-2.
8
Accessing opiate dependence treatment medications: buprenorphine products in an office-based setting.
Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S103-4. doi: 10.1016/s0376-8716(03)00063-2.
9
Use of buprenorphine in pregnancy: patient management and effects on the neonate.
Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S87-101. doi: 10.1016/s0376-8716(03)00062-0.
10
Buprenorphine: how to use it right.
Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S59-77. doi: 10.1016/s0376-8716(03)00060-7.
Zotero 插件